Advertisement

Topics

Addex Pharmaceuticals Company Profile

16:46 EDT 20th June 2018 | BioPortfolio


News Articles [540 Associated News Articles listed on BioPortfolio]

Addex Pharmaceuticals and the Pursuit of the True Innovation

In this conversation with Dr. Vincent Mutel, co-founder and CEO of Addex Pharmaceuticals, Fintan Walton reveals how the Addex mission—to achieve true innovation—has contributed to the tremendous s...

Addex Therapeutics Ltd: Addex Publishes Extraordinary General Meeting Invitation

Geneva, Switzerland, 23 February 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that it has published the In...

Addex Therapeutics: Addex Publishes Extraordinary General Meeting Invitation

Addex Therapeutics / Addex Publishes Extraordinary General Meeting Invitation . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this ann...

Addex Therapeutics Ltd: Addex Secures Investor Commitment for CHF40 million Capital Increase Following Successful Completion of Book Building Process

Geneva, Switzerland, 5 March 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that the Company has secured inv...

Addex Therapeutics: Addex Therapeutics Equity Research Report Update Issued by valuationLAB

Addex Therapeutics / Addex Therapeutics Equity Research Report Update Issued by valuationLAB . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the cont...

Addex Therapeutics Ltd: Addex Therapeutics Equity Research Report Update Issued by valuationLAB

Report estimates a current value of ADXN of CHF 12.5 per share Geneva, Switzerland, 8 January 2018 - Addex Therapeutics (SIX: ADXN) announced today that the independent life science equity researc...

Addex Therapeutics: Swiss Takeover Board Validates New Article 39 (Opting-Out Provision) of Addex Articles of Association

Addex Therapeutics / Swiss Takeover Board Validates New Article 39 (Opting-Out Provision) of Addex Articles of Association . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is s...

Addex Therapeutics: Addex Launches CHF40 million Capital Increase with Commitment from Specialist US Healthcare Investors

Addex Therapeutics / Addex Launches CHF40 million Capital Increase with Commitment from Specialist US Healthcare Investors . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is s...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [133 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Environmental concentrations of pharmaceuticals directly affect phytoplankton and effects propagate through trophic interactions.

Pharmaceuticals are found in freshwater ecosystems where even low concentrations in the range of ng Lmay affect aquatic organisms. In the current study, we investigated the effects of chronic exposure...

Clinical Trials [215 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1322 Associated Companies listed on BioPortfolio]

Addex Pharmaceuticals

Addex Therapeutics

Addex Therapeutics is pioneering discovery and development of an emerging class of oral small molecule drugs, called allosteric modulators, which can be exquisitely selective for their intended targ...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

More Information about "Addex Pharmaceuticals" on BioPortfolio

We have published hundreds of Addex Pharmaceuticals news stories on BioPortfolio along with dozens of Addex Pharmaceuticals Clinical Trials and PubMed Articles about Addex Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Addex Pharmaceuticals Companies in our database. You can also find out about relevant Addex Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record